← FDA DRUG APPROVALS

FDA ANDA · ANDA087203

FLURANDRENOLIDE

Sponsor: ALPHARMA US PHARMS

APPLICATION
ANDA087203
TYPE
ANDA
ORIGINAL APPROVAL
1982-04-29
LATEST ACTION
1991-10-18
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Discontinued

Products

FLURANDRENOLIDEDiscontinued
FLURANDRENOLIDE 0.05% · LOTION · TOPICAL

Approval history

1991-10-18Labeling · Supplement 10AP
1988-05-27Labeling · Supplement 7AP
1982-04-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →